Advertisement
Canada markets open in 4 hours 16 minutes

  • S&P/TSX

    21,793.90
    +5.42 (+0.02%)
     

  • S&P 500

    5,477.90
    +8.60 (+0.16%)
     

  • DOW

    39,127.80
    +15.64 (+0.04%)
     

  • CAD/USD

    0.7308
    +0.0009 (+0.12%)
     

  • CRUDE OIL

    81.39
    +0.49 (+0.61%)
     

  • Bitcoin CAD

    83,287.02
    -813.31 (-0.97%)
     

  • CMC Crypto 200

    1,263.54
    -2.61 (-0.21%)
     

  • GOLD FUTURES

    2,319.90
    +6.70 (+0.29%)
     

  • RUSSELL 2000

    2,018.12
    -4.23 (-0.21%)
     

  • 10-Yr Bond

    4.3160
    +0.0780 (+1.84%)
     

  • NASDAQ futures

    19,959.75
    -52.75 (-0.26%)
     

  • VOLATILITY

    12.72
    +0.17 (+1.35%)
     

  • FTSE

    8,217.75
    -7.58 (-0.09%)
     

  • NIKKEI 225

    39,341.54
    -325.53 (-0.82%)
     

  • CAD/EUR

    0.6833
    +0.0002 (+0.03%)
     

BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts

PR Newswire
·2 min read

FRANKLIN LAKES, N.J., June 20, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it plans to host webcasts to discuss quarterly financial results on the following dates:

  • Third Quarter Fiscal 2024 —Thursday, August 1, 2024 at 8:00 a.m. (ET)

  • Fourth Quarter Fiscal 2024 — Thursday, November 7, 2024 at 8:00 a.m. (ET)

BD will issue a detailed announcement prior to each quarter's webcast, confirming the date and time of the earnings news release and webcast for that quarter.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.

Contacts:




Media:

Investors:

Troy Kirkpatrick

Adam Reiffe

VP, Public Relations

Sr. Director, Investor Relations

858.617.2361

201.847.6927

troy.kirkpatrick@bd.com

adam.reiffe@bd.com 

 

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/bd-announces-dates-for-third-quarter-and-fourth-quarter-fiscal-2024-earnings-webcasts-302177495.html

SOURCE BD (Becton, Dickinson and Company)